NCT04512118View on ClinicalTrials.gov

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

July 30, 2020

Conditions
Presence of COVID-19 Compatible CT Abnormalities
Interventions
DIAGNOSTIC_TEST

PET-CT of 18F-FDG

Whole-body 18F-FDG-PET/CT was performed on a digital hybrid system (Vereos, Philips®)

Trial Locations (1)

54511

CHRU of Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04512118 - CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients | Biotech Hunter | Biotech Hunter